pdfcrowd.comopen in browserPRO version
Are you a developer? Try out theHTML to PDF API
who got together to discuss the important of social mediawithin the healthcare industry. As I have noticed with the majority of forums on this subject, there wasn't much conversationaround social media related specifically to pharmaceutical companies or products becauseeveryone is anticipating theU.S. Food and Drug Administration (FDA) guidelines. (There hasbeen much speculation as to when these guidelines will be announced - it was mentionedduring this event that the guidelines won't likely surface until at least next year.) Thoughpharma may not be ready to dive in, consumers and patients want to have the vehicle toconnect with companies directly. This will be huge opportunity for pharma to help convey safetyinformation, clear any confusion and help improve compliance.Even though pharmaceuticals were not the main topic of the day, the forum nonethelessshared a lot of advice and statistics that are very interesting and relevant to healthcarecommunicators. Here are the top five key takeaways from the forum:1. 100 million U.S. adults are using social media for health advice - this remains consistentwith data we've seen about healthcare information on the Web.2. 70 percent of people will believe health information coming from people they've never met,and 81 percent of women will believe information from other women that they've never met.3. 37 percent of all clinicians reported using social media for professional networking, and 64percent of them would choose Facebook if they could choose only one social networkingsite.4. 37 percent of physicians use healthcare-related mobile apps, and 17 percent of them usetheir mobile device for healthcare-related content.5. In the absence of FDA guidelines, companies should look to the following rules:Be truthful.Provide fair balance.Give adequate disclosure of risk.Don't be misleading.So what does this all mean for our healthcare clients? Your key customers and patients takingyour medications want the opportunity to interact with you online the same way they do aboutother products that they consume every day. The opportunities are endless, so, while the FDAworks to determine appropriate guidelines, pharma needs to get ready. Start listening,educating and building consensus internally about social media policies from the top down. Thechance to join the conversation may be just around the corner.
“Ome” has become for molecular biology what“gate” is to American scandal – a shorthandsuffix that links a new concept or event to anoriginal (“genome”, “Watergate”).The current (February) issue of
NatureReviews: Drug Discovery
contains a “comment”(http://...Read more >
Really interestingperspective on healthcare in Russia.Looking forward to more updates onnew developments. Nancy Hicks Senior VicePresident Associate Director, North AmericaHealthcare Practice...
What Russian Patients Think of Healthcare·3 weeks ago
Directors’ WelcomeFriends and Colleagues, Exeter Medical Center is a specializedOrthopaedic Center based in Abu Dhabi, thefast growing capital of United Arab of Emirates. Aligning with the UAE...
Weqaya: Abu Dhabi’s Move to Transform Public Health·3months ago
Excellent insights Andy.It's really fascinating to consider theimplications of FDA decisions beyondthe borders of the US. Completely agree that